Histological Classification of Breast Cancer.- Biomarkers for Breast Cancer: Towards the Proposition of Clinically Relevant Tools.- Circulating Tumour Markers in Breast Cancer.- Axillary Lymph Node Status Evaluation in Breast Cancer Patients: Role of SPECT and Pinhole SPECT with Cationic Lipophilic Radiotracers.- Breast Imaging with Scintimammography.- 99mTc-MIBI in the Evaluation of Breast Cancer Biology.- Sentinel Node Detection in Pre-Operative Axillary Staging.- State of the Art of Current Modalities for the Diagnosis of Breast Lesions.- New Trends of MRI in Breast Cancer Diagnosis.- PET Imaging of Breast Cancer Molecular Biomarkers.- The Role of FDG-PET for Axillary Lymph Node Staging in Primary Breast Cancer.- Measuring Response to Chemotherapy in Locally Advanced Breast Cancer: Methodological Considerations.- FDG-PET in Monitoring Therapy of Breast Cancer.- FDG-PET and Tumour Marker Tests for the Diagnosis of Breast Cancer.- Advantages and Limitations of FDG PET 16 in the Follow-Up of Breast Cancer.- PET/CT and Breast Cancer.- Current Role of Bone Scan with Phosphonates in the Follow-Up of Breast Cancer.- Progress in the Treatment of Early and Advanced Breast Cancer.- 186Re-HEDP for Metastatic Bone Pain in Breast Cancer Patients.- 153Sm-EDTM for Bone Pain Treatment in Skeletal Metastases.- The Choice of the Correct Imaging Modality in Breast Cancer Management.
Histological Classification of Breast Cancer.- Biomarkers for Breast Cancer: Towards the Proposition of Clinically Relevant Tools.- Circulating Tumour Markers in Breast Cancer.- Axillary Lymph Node Status Evaluation in Breast Cancer Patients: Role of SPECT and Pinhole SPECT with Cationic Lipophilic Radiotracers.- Breast Imaging with Scintimammography.- 99mTc-MIBI in the Evaluation of Breast Cancer Biology.- Sentinel Node Detection in Pre-Operative Axillary Staging.- State of the Art of Current Modalities for the Diagnosis of Breast Lesions.- New Trends of MRI in Breast Cancer Diagnosis.- PET Imaging of Breast Cancer Molecular Biomarkers.- The Role of FDG-PET for Axillary Lymph Node Staging in Primary Breast Cancer.- Measuring Response to Chemotherapy in Locally Advanced Breast Cancer: Methodological Considerations.- FDG-PET in Monitoring Therapy of Breast Cancer.- FDG-PET and Tumour Marker Tests for the Diagnosis of Breast Cancer.- Advantages and Limitations of FDG PET 16 in the Follow-Up of Breast Cancer.- PET/CT and Breast Cancer.- Current Role of Bone Scan with Phosphonates in the Follow-Up of Breast Cancer.- Progress in the Treatment of Early and Advanced Breast Cancer.- 186Re-HEDP for Metastatic Bone Pain in Breast Cancer Patients.- 153Sm-EDTM for Bone Pain Treatment in Skeletal Metastases.- The Choice of the Correct Imaging Modality in Breast Cancer Management.
Histological Classification of Breast Cancer.- Biomarkers for Breast Cancer: Towards the Proposition of Clinically Relevant Tools.- Circulating Tumour Markers in Breast Cancer.- Axillary Lymph Node Status Evaluation in Breast Cancer Patients: Role of SPECT and Pinhole SPECT with Cationic Lipophilic Radiotracers.- Breast Imaging with Scintimammography.- 99mTc-MIBI in the Evaluation of Breast Cancer Biology.- Sentinel Node Detection in Pre-Operative Axillary Staging.- State of the Art of Current Modalities for the Diagnosis of Breast Lesions.- New Trends of MRI in Breast Cancer Diagnosis.- PET Imaging of Breast Cancer Molecular Biomarkers.- The Role of FDG-PET for Axillary Lymph Node Staging in Primary Breast Cancer.- Measuring Response to Chemotherapy in Locally Advanced Breast Cancer: Methodological Considerations.- FDG-PET in Monitoring Therapy of Breast Cancer.- FDG-PET and Tumour Marker Tests for the Diagnosis of Breast Cancer.- Advantages and Limitations of FDG PET 16 in the Follow-Up of Breast Cancer.- PET/CT and Breast Cancer.- Current Role of Bone Scan with Phosphonates in the Follow-Up of Breast Cancer.- Progress in the Treatment of Early and Advanced Breast Cancer.- 186Re-HEDP for Metastatic Bone Pain in Breast Cancer Patients.- 153Sm-EDTM for Bone Pain Treatment in Skeletal Metastases.- The Choice of the Correct Imaging Modality in Breast Cancer Management.
Histological Classification of Breast Cancer.- Biomarkers for Breast Cancer: Towards the Proposition of Clinically Relevant Tools.- Circulating Tumour Markers in Breast Cancer.- Axillary Lymph Node Status Evaluation in Breast Cancer Patients: Role of SPECT and Pinhole SPECT with Cationic Lipophilic Radiotracers.- Breast Imaging with Scintimammography.- 99mTc-MIBI in the Evaluation of Breast Cancer Biology.- Sentinel Node Detection in Pre-Operative Axillary Staging.- State of the Art of Current Modalities for the Diagnosis of Breast Lesions.- New Trends of MRI in Breast Cancer Diagnosis.- PET Imaging of Breast Cancer Molecular Biomarkers.- The Role of FDG-PET for Axillary Lymph Node Staging in Primary Breast Cancer.- Measuring Response to Chemotherapy in Locally Advanced Breast Cancer: Methodological Considerations.- FDG-PET in Monitoring Therapy of Breast Cancer.- FDG-PET and Tumour Marker Tests for the Diagnosis of Breast Cancer.- Advantages and Limitations of FDG PET 16 in the Follow-Up of Breast Cancer.- PET/CT and Breast Cancer.- Current Role of Bone Scan with Phosphonates in the Follow-Up of Breast Cancer.- Progress in the Treatment of Early and Advanced Breast Cancer.- 186Re-HEDP for Metastatic Bone Pain in Breast Cancer Patients.- 153Sm-EDTM for Bone Pain Treatment in Skeletal Metastases.- The Choice of the Correct Imaging Modality in Breast Cancer Management.
Rezensionen
From the reviews:
"This book provides a complete overview of the diagnostic and therapeutic aspects of nuclear medicine in breast cancer. ... The audience includes nuclear medicine professions, radiologists, oncologists, and residents and fellows in those fields. This book is a valuable aid for new practitioners as well as experienced nuclear medicine physicians who are called upon for treatment of breast cancer. ... This excellent book will be a great addition to any nuclear medicine physician's library ... ." (Oussama Nachar, Doody's Review Service, February, 2008)
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497